Edwards Lifesciences annual return on equity
2009
2010
2021
2022
2023
2024
2025
Edwards Lifesciences Return on Equity (ROE) Growth & History (EW)
Edwards Lifesciences's return on equity was 10.56% for fiscal 2025.
View full Edwards Lifesciences company overviewEdwards Lifesciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 10.56% | −39.59 pp |
| 2024 | 2024-12-31 | 50.15% | +27.63 pp |
| 2023 | 2023-12-31 | 22.52% | −3.63 pp |
| 2022 | 2022-12-31 | 26.14% | −2.73 pp |
| 2021 | 2021-12-31 | 28.88% | — |
| 2010 | 2010-12-31 | 17.68% | −4.82 pp |
| 2009 | 2009-12-31 | 22.50% | — |
Edwards Lifesciences quarterly return on equity
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.31% | −0.91 pp |
| Q1 2026 | 2026-03-31 | 3.68% | +0.13 pp |
| Q4 2025 | 2025-12-31 | 0.89% | −3.06 pp |
| Q3 2025 | 2025-09-30 | 2.81% | −33.36 pp |
| Q2 2025 | 2025-06-30 | 3.22% | −1.81 pp |
| Q1 2025 | 2025-03-31 | 3.56% | −1.55 pp |
| Q4 2024 | 2024-12-31 | 3.95% | −1.61 pp |
| Q3 2024 | 2024-09-30 | 36.16% | +30.26 pp |
| Q2 2024 | 2024-06-30 | 5.03% | +0.06 pp |
| Q1 2024 | 2024-03-31 | 5.11% | −0.67 pp |
| Q4 2023 | 2023-12-31 | 5.56% | −1.07 pp |
| Q3 2023 | 2023-09-30 | 5.91% | +0.26 pp |
| Q2 2023 | 2023-06-30 | 4.97% | −1.92 pp |
| Q1 2023 | 2023-03-31 | 5.78% | −0.62 pp |
| Q4 2022 | 2022-12-31 | 6.63% | — |
| Q3 2022 | 2022-09-30 | 5.65% | — |
| Q2 2022 | 2022-06-30 | 6.89% | — |
| Q1 2022 | 2022-03-31 | 6.40% | — |
| Q2 2011 | 2011-06-30 | 4.24% | −0.82 pp |
| Q1 2011 | 2011-03-31 | 4.79% | — |
| Q4 2010 | 2010-12-31 | 5.10% | — |
| Q3 2010 | 2010-09-30 | 4.08% | — |
| Q2 2010 | 2010-06-30 | 5.05% | — |
Edwards Lifesciences return on equity trends
Between the periods ended 2009-12-31 and 2025-12-31, Edwards Lifesciences's return on equity decreased from 22.50% to 10.56%, a change of −11.94 percentage points. The latest reported quarter, Q2 2026, shows 2.31%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edwards Lifesciences source filings ↗